# FDA Inspection 1031301 - Vitalant - October 24, 2017

Source: https://www.keypedia.com/records/fda_inspections/vitalant/d366267f-5ec2-4f67-a5e8-525b4e52b86d
Source feed: FDA_Inspections

> FDA Inspection 1031301 for Vitalant on October 24, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031301
- Company Name: Vitalant
- Inspection Date: 2017-10-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1158786 - 2021-11-30](https://www.keypedia.com/records/fda_inspections/vitalant/3bdaf667-c098-4aba-8dfd-f5aa4ad9a96d)
- [FDA Inspection 1158786 - 2021-11-30](https://www.keypedia.com/records/fda_inspections/vitalant/9ce057e4-4664-4131-989d-a904d4f61031)
- [FDA Inspection 951016 - 2015-10-16](https://www.keypedia.com/records/fda_inspections/vitalant/15591453-6747-4b92-991a-bc857ed9db22)
- [FDA Inspection 853372 - 2013-10-30](https://www.keypedia.com/records/fda_inspections/vitalant/aaf27b91-8495-441e-94aa-16c8e79e8918)
- [FDA Inspection 752062 - 2011-11-02](https://www.keypedia.com/records/fda_inspections/vitalant/23a0c01f-4dfd-4870-9df3-110956f9a896)

Company: https://www.keypedia.com/companies/vitalant/9f6c952e-8522-4102-b129-fdccc33e2a44

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d